Genzyme currently has three facilities in Framingham, the Genzyme Science Center at 49 New York Ave, and offices at 200 Crossing Blvd and 11 Pleasant Street.
FRAMINGHAM, MA - This week, Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced that it is investing $80 million to build a new downstream processing facility for Fabrazyme® (agalsidase beta).
The new plant, which will be located adjacent to the new Fabrazyme cell culture manufacturing site in Framingham, Massachusetts, will significantly expand purification capacity to support anticipated growth in global demand over the coming years.
“As we continue to meet the global demands for Fabrazyme and build inventory, our focus also remains on the future needs of the global Fabry community,” said Genzyme President and CEO, David Meeker, M.D. “Following last year’s regulatory approvals of our manufacturing facility in Framingham and ...[read more]
Comments Off on Genzyme to Invest $80M in Framingham Plant
FRAMINGHAM, MA - Most people who have lived in Framingham for more than 30 or 40 years refer to the ice cream production facility on Old Connecticut Path, (across from the top of Speen Street), simply as "Sealtest" -- even though it hasn't produced Sealtest ice-cream for many years.
In-fact, no ice-cream at all has been made at the Framingham plant since April 31, 2011. That's when Unilever, the multi-national consumer product manufacturing conglomerate which owns the Sealtest, Breyer's and Good Humor ice-cream brands finally shut down the factory.
It wasn't a sudden closing, for a couple years Unilever had been warning the last 200 or so employees they would be shifting production to other facilities where utilities, taxes and wages would cost the company less.
After hearing the final days for the plant were numbered, in March (2011), Michael Montville who grew up in Bellingham, (and now lives in Danielson CT), made ...[read more]